Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months.

Abstract:

OBJECTIVE:Some children with type 1 diabetes may be at risk of cognitive impairments, but mechanisms of this effect have not been confirmed. The objective of this study was to determine whether severe hypoglycemia (SH) in children with type 1 diabetes is associated with cognitive decline over 18 months. RESEARCH DESIGN AND METHODS:A sample of 142 6- to 15-year-old children with type 1 diabetes (mean age 11.6 +/- 2.7 years) enrolled in a trial of intensive therapy (IT) or usual care (UC) were tested with the Das-Naglieri Cognitive Assessment System at baseline and after 9 and 18 months. Episodes of SH were recorded by parents and reported promptly for verification by study nurses. HbA(1c) was measured quarterly. RESULTS:Over 18 months, 58 of 142 patients (41%) experienced 111 SH episodes, with a RR of SH of 1.12 for IT over UC. Neither occurrence nor frequency of SH was associated with decline in full-scale intelligence quotient (IQ), standard scores for planning, attention, simultaneous processing, or successive processing, or scaled scores on any of eight subtests. The same findings emerged when only patients who had experienced hypoglycemic seizures or coma were included in the SH group for analyses. These effects persisted when the child's age, sex, type 1 diabetes duration, and age at diagnosis were controlled statistically. HbA(1c) during the trial was not associated with cognitive changes. CONCLUSIONS:SH did not induce adverse changes in the measures of cognitive function administered to 6- to 15-year-old children with type 1 diabetes in this study. Although SH should be avoided in all children with diabetes, these episodes did not have adverse effects on cognition in this age-group over 18 months.

journal_name

Diabetes Care

journal_title

Diabetes care

authors

Wysocki T,Harris MA,Mauras N,Fox L,Taylor A,Jackson SC,White NH

doi

10.2337/diacare.26.4.1100

subject

Has Abstract

pub_date

2003-04-01 00:00:00

pages

1100-5

issue

4

eissn

0149-5992

issn

1935-5548

journal_volume

26

pub_type

杂志文章,多中心研究
  • Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey.

    abstract:OBJECTIVE:1) To examine trends in the use of diabetes medications and 2) to determine whether physicians individualize diabetes treatment as recommended by the American Diabetes Association (ADA). RESEARCH DESIGN AND METHODS:We conducted a retrospective, cross-sectional analysis of 2003-2016 National Health and Nutrit...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc19-2424

    authors: Le P,Chaitoff A,Misra-Hebert AD,Ye W,Herman WH,Rothberg MB

    更新日期:2020-06-01 00:00:00

  • Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study.

    abstract:OBJECTIVE:To test the hypothesis that lower vital capacity is cross-sectionally associated with features of insulin resistance and is an independent predictor of incident type 2 diabetes. RESEARCH DESIGN AND METHODS:We conducted a prospective cohort study of vital capacity as a predictor of incident type 2 diabetes us...

    journal_title:Diabetes care

    pub_type: 杂志文章,多中心研究

    doi:10.2337/diacare.28.6.1472

    authors: Yeh HC,Punjabi NM,Wang NY,Pankow JS,Duncan BB,Brancati FL

    更新日期:2005-06-01 00:00:00

  • Does knowing one's elevated glycemic status make a difference in macronutrient intake?

    abstract:OBJECTIVE:To determine whether macronutrient intake differs by awareness of glycemic status among people with diabetes and prediabetes. RESEARCH DESIGN AND METHODS:We used 24-h dietary recall and other data from 3,725 nonpregnant adults with diabetes or prediabetes aged ≥20 years from the morning fasting sample of the...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc14-1342

    authors: Bardenheier BH,Cogswell ME,Gregg EW,Williams DE,Zhang Z,Geiss LS

    更新日期:2014-12-01 00:00:00

  • High-risk individuals' willingness to pay for diabetes risk-reduction programs.

    abstract:OBJECTIVE:The purpose of this study was to estimate how much at-risk individuals are willing to pay for type 2 diabetes primary prevention programs. RESEARCH DESIGN AND METHODS:An Internet-based, choice-format conjoint survey was presented to individuals at elevated risk for type 2 diabetes. Hypothetical diabetes risk...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc05-2221

    authors: Johnson FR,Manjunath R,Mansfield CA,Clayton LJ,Hoerger TJ,Zhang P

    更新日期:2006-06-01 00:00:00

  • Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With Type 2 Diabetes and Depression: Results From a Randomized Placebo-Controlled Trial.

    abstract:OBJECTIVE:Depression is common in patients with type 2 diabetes and adversely affects quality of life and diabetes outcomes. We assessed whether light therapy, an antidepressant, improves mood and insulin sensitivity in patients with depression and type 2 diabetes. RESEARCH DESIGN AND METHODS:This randomized, double-b...

    journal_title:Diabetes care

    pub_type: 杂志文章,随机对照试验

    doi:10.2337/dc18-1732

    authors: Brouwer A,van Raalte DH,Nguyen HT,Rutters F,van de Ven PM,Elders PJM,Moll AC,Van Someren EJW,Snoek FJ,Beekman ATF,Bremmer MA

    更新日期:2019-04-01 00:00:00

  • Pancreas transplantation improves vascular disease in patients with type 1 diabetes.

    abstract:OBJECTIVE:Pancreas transplantation (PTX) normalizes glucose and improves microvascular complications, but its impact on macrovascular disease is still debated. RESEARCH DESIGN AND METHODS:Carotid intima-media thickness (IMT), shown to correlate with cardiovascular disease (CVD) risk and events, was determined prospect...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.27.7.1706

    authors: Larsen JL,Colling CW,Ratanasuwan T,Burkman TW,Lynch TG,Erickson JM,Lyden ER,Lane JT,Mack-Shipman LR

    更新日期:2004-07-01 00:00:00

  • Cholesterol absorption and synthesis in children with type 1 diabetes.

    abstract:OBJECTIVE:The levels of the surrogate markers of cholesterol absorption (cholestanol and plant sterols) and synthesis (cholesterol precursors) in serum have suggested that in adult type 1 diabetes, cholesterol absorption is high and synthesis is low compared with type 2 diabetic or control subjects. Accordingly, these ...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc05-2235

    authors: Järvisalo M,Raitakari O,Gylling H,Miettinen TA

    更新日期:2006-10-01 00:00:00

  • Evaluation of postural stability in elderly with diabetic neuropathy.

    abstract:OBJECTIVE:The objective of this study was to compare clinical and biomechanical characteristics of balance in diabetic polyneuropathic elderly patients and normal age-matched subjects. RESEARCH DESIGN AND METHODS:Fifteen elderly with distal neuropathy (DNP) and 15 healthy age-matched subjects were evaluated with the b...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.23.8.1187

    authors: Corriveau H,Prince F,Hébert R,Raîche M,Tessier D,Maheux P,Ardilouze JL

    更新日期:2000-08-01 00:00:00

  • Incidence of stroke according to presence of diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetes.

    abstract:OBJECTIVE:Type 1 diabetes is associated with a markedly increased risk of stroke, but only a few studies on the incidence of stroke in type 1 diabetes exist. Therefore, we assessed the incidence of stroke in patients with type 1 diabetes and studied the impact of diabetic nephropathy (DN) and severe diabetic retinopath...

    journal_title:Diabetes care

    pub_type: 杂志文章,多中心研究

    doi:10.2337/dc13-0669

    authors: Hägg S,Thorn LM,Putaala J,Liebkind R,Harjutsalo V,Forsblom CM,Gordin D,Tatlisumak T,Groop PH,FinnDiane Study Group.

    更新日期:2013-12-01 00:00:00

  • Improvements in patient-reported outcomes associated with an intervention to enhance quality of care for rural patients with type 2 diabetes: results of a controlled trial.

    abstract:OBJECTIVE:The aim of this study was to examine patient-reported outcomes in a controlled trial of a multifaceted provider-level intervention to improve quality of care for rural patients with type 2 diabetes. RESEARCH DESIGN AND METHODS:We conducted a before/after intervention study with concurrent controls in two rur...

    journal_title:Diabetes care

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.2337/diacare.27.6.1306

    authors: Maddigan SL,Majumdar SR,Guirguis LM,Lewanczuk RZ,Lee TK,Toth EL,Johnson JA

    更新日期:2004-06-01 00:00:00

  • Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data.

    abstract:OBJECTIVE:To test the conclusion that there is no association between multiple episodes of severe hypoglycemia and cognitive decrements by reanalyzing the data from the Diabetes Control and Complications Trial (DCCT) with psychometrically validated cognitive factors and to conduct a novel analysis of the association be...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.22.8.1273

    authors: Austin EJ,Deary IJ

    更新日期:1999-08-01 00:00:00

  • Effect of diabetes on renal medullary oxygenation during water diuresis.

    abstract:OBJECTIVES:To study the effect of water diuresis on renal medullary and cortical oxygenation in patients with diabetes using blood oxygenation level--dependent magnetic resonance imaging (BOLD MRI). RESEARCH DESIGN AND METHODS:Nine mild diabetic subjects (48 +/- 2.7 years of age, six women) and nine nondiabetic subjec...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.25.3.575

    authors: Epstein FH,Veves A,Prasad PV

    更新日期:2002-03-01 00:00:00

  • Prediction of type 1 diabetes in the general population.

    abstract:OBJECTIVE:To evaluate the utility of GAD antibodies (GADAs) and islet antigen-2 antibodies (IA-2As) in prediction of type 1 diabetes over 27 years in the general population and to assess the 6-year rates of seroconversion. RESEARCH DESIGN AND METHODS:A total of 3,475 nondiabetic subjects aged 3-18 years were sampled i...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc09-1040

    authors: Knip M,Korhonen S,Kulmala P,Veijola R,Reunanen A,Raitakari OT,Viikari J,Akerblom HK

    更新日期:2010-06-01 00:00:00

  • Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.

    abstract:OBJECTIVE:Insulin resistance plays a part in diabetic nephropathy (DN). The association between the peroxisome proliferator-activated receptor γ Pro to Ala alteration at codon 12 (Pro12Ala) polymorphism and the risk of insulin resistance has been confirmed. The association between the polymorphism and DN risk has also ...

    journal_title:Diabetes care

    pub_type: 杂志文章,meta分析

    doi:10.2337/dc11-2142

    authors: Zhang H,Zhu S,Chen J,Tang Y,Hu H,Mohan V,Venkatesan R,Wang J,Chen H

    更新日期:2012-06-01 00:00:00

  • Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment.

    abstract:OBJECTIVE:Determine the serum levels of endogenous secretory receptor for advanced glycation end products (esRAGEs) in patients with type 2 diabetes and mild cognitive impairment (MCI) and in control patients with type 2 diabetes but no MCI, and examine the relationship of esRAGE and MCI with other clinical factors. R...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc11-0958

    authors: Chen G,Cai L,Chen B,Liang J,Lin F,Li L,Lin L,Yao J,Wen J,Huang H

    更新日期:2011-12-01 00:00:00

  • Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial.

    abstract:OBJECTIVE:Although initially effective, sulfonylureas are associated with poor glycemic durability, weight gain, and hypoglycemia. Dapagliflozin, a selective inhibitor of sodium-glucose cotransporter 2 (SGLT2), reduces hyperglycemia by increasing urinary glucose excretion independent of insulin and may cause fewer of t...

    journal_title:Diabetes care

    pub_type: 杂志文章,随机对照试验

    doi:10.2337/dc11-0606

    authors: Nauck MA,Del Prato S,Meier JJ,Durán-García S,Rohwedder K,Elze M,Parikh SJ

    更新日期:2011-09-01 00:00:00

  • Systematic review of herbs and dietary supplements for glycemic control in diabetes.

    abstract:OBJECTIVE:To conduct a systematic review of the published literature on the efficacy and safety of herbal therapies and vitamin/mineral supplements for glucose control in patients with diabetes. RESEARCH DESIGN AND METHODS:We conducted an electronic literature search of MEDLINE, OLDMEDLINE, Cochrane Library Database, ...

    journal_title:Diabetes care

    pub_type: 杂志文章,评审

    doi:10.2337/diacare.26.4.1277

    authors: Yeh GY,Eisenberg DM,Kaptchuk TJ,Phillips RS

    更新日期:2003-04-01 00:00:00

  • Insulin-resistant diabetes with insulin receptor autoantibodies in a male patient without acanghosis nigricans.

    abstract::A 51-yr-old, nonobese, male patient presented with hyperglycemia and a recent 40-pound weight loss. Severe insulin resistance was documented in studies in which high amounts of insulin were infused using the Biostator GCIIS. Diabetic control was finally achieved with subcutaneous injections of 470 U of insulin per day...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.2.3.275

    authors: Baldwin D Jr,Winston E,Hoshizaki RJ,Garland JT,Baldwin D Sr,Holcomb HH,Flier JS,Rubenstein A

    更新日期:1979-05-01 00:00:00

  • Effect of rosiglitazone versus insulin on the pancreatic beta-cell function of subjects with type 2 diabetes.

    abstract:OBJECTIVE:In a previous study, we found observational evidence of improvement in beta-cell function when rosiglitazone was added to a failing oral antihyperglycemic regimen consisting of sulfonylureas and metformin. To confirm our previous observations, we designed and performed a prospective, randomized, and controlle...

    journal_title:Diabetes care

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.2337/diacare.27.11.2585

    authors: Ovalle F,Bell DS

    更新日期:2004-11-01 00:00:00

  • Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men.

    abstract:OBJECTIVE:Defects in insulin secretion and insulin action are the major abnormalities in the development of type 2 diabetes. In middle-aged subjects, elevated plasma proinsulin has been found to predict type 2 diabetes. Therefore, our aim was to study the longitudinal relationships between baseline determinations of in...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.27.6.1433

    authors: Zethelius B,Hales CN,Lithell HO,Berne C

    更新日期:2004-06-01 00:00:00

  • Quantitative estimation of insulin sensitivity in type 1 diabetic subjects wearing a sensor-augmented insulin pump.

    abstract:OBJECTIVE:The goal was to develop a new index of insulin sensitivity in patients with type 1 diabetes estimated from continuous glucose monitoring (CGM) and subcutaneous insulin delivery data under carefully controlled conditions. RESEARCH DESIGN AND METHODS:The database consists of 12 subjects with type 1 diabetes, s...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc13-1120

    authors: Schiavon M,Dalla Man C,Kudva YC,Basu A,Cobelli C

    更新日期:2014-01-01 00:00:00

  • Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis.

    abstract:OBJECTIVE:People with diabetes have an increased risk of coronary artery disease (CAD). An unanswered question is what portion of CAD can be attributed to insulin resistance, related metabolic variables, and other known CAD risk factors. RESEARCH DESIGN AND METHODS:The Archimedes model was used to estimate the proport...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc08-0854

    authors: Eddy D,Schlessinger L,Kahn R,Peskin B,Schiebinger R

    更新日期:2009-02-01 00:00:00

  • Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.

    abstract:OBJECTIVE:It is known that continuous glucose monitoring (CGM) systems can lower mean glucose compared with episodic self-monitoring of blood glucose. Implantable CGM systems may provide additional benefits. RESEARCH DESIGN AND METHODS:We studied the Eversense (Senseonics Inc.) implantable CGM sensor in 71 participant...

    journal_title:Diabetes care

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.2337/dc16-1525

    authors: Kropff J,Choudhary P,Neupane S,Barnard K,Bain SC,Kapitza C,Forst T,Link M,Dehennis A,DeVries JH

    更新日期:2017-01-01 00:00:00

  • The evaluation of a pocket computer as an aid to insulin dose determination by patients.

    abstract::A small and inexpensive computer was programmed to assist patients in making decisions regarding insulin delivery using constant subcutaneous infusion systems. Insulin dosage was based on gender, pre- and postprandial blood glucose, between-meal blood glucose, patient weight, time of day, and when appropriate, the car...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.8.2.172

    authors: Chanoch LH,Jovanovic L,Peterson CM

    更新日期:1985-03-01 00:00:00

  • Plasma Lipidome and Prediction of Type 2 Diabetes in the Population-Based Malmö Diet and Cancer Cohort.

    abstract:OBJECTIVE:Type 2 diabetes mellitus (T2DM) is associated with dyslipidemia, but the detailed alterations in lipid species preceding the disease are largely unknown. We aimed to identify plasma lipids associated with development of T2DM and investigate their associations with lifestyle. RESEARCH DESIGN AND METHODS:At ba...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc19-1199

    authors: Fernandez C,Surma MA,Klose C,Gerl MJ,Ottosson F,Ericson U,Oskolkov N,Ohro-Melander M,Simons K,Melander O

    更新日期:2020-02-01 00:00:00

  • Reduction in carotid intima-media thickness after pancreatic islet transplantation in patients with type 1 diabetes.

    abstract:OBJECTIVE:Determine the impact of islet transplantation on carotid intima-media thickness (CIMT), a marker for atherosclerosis, in type 1 diabetes without kidney disease. RESEARCH DESIGN AND METHODS:Consecutive case series of 15 adults (mean age [SD], 49 years [10 years]; 87% female) with type 1 diabetes for ≥5 years ...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc12-0679

    authors: Danielson KK,Hatipoglu B,Kinzer K,Kaplan B,Martellotto J,Qi M,Mele A,Benedetti E,Oberholzer J

    更新日期:2013-02-01 00:00:00

  • Measuring diabetes self-care: a psychometric analysis of the Self-Care Inventory-Revised with adults.

    abstract:OBJECTIVE:To examine psychometric properties of the Self-Care Inventory-revised (SCI-R), a self-report measure of perceived adherence to diabetes self-care recommendations, among adults with diabetes. RESEARCH DESIGN AND METHODS:We used three data sets of adult type 1 and type 2 diabetic patients to examine psychometr...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.28.6.1346

    authors: Weinger K,Butler HA,Welch GW,La Greca AM

    更新日期:2005-06-01 00:00:00

  • Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia.

    abstract:OBJECTIVE:Sulfonylureas block the activation of vascular potassium-dependent ATP channels and impair the vasodilating response to ischcmia in nondiabetic individuals, but it is not know whether this occurs in type 2 diabetic patients under chronic treatment with these drugs. Glimepiride, a new sulfonylurea, apparently ...

    journal_title:Diabetes care

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.2337/diacare.24.4.738

    authors: Spallarossa P,Schiavo M,Rossettin P,Cordone S,Olivotti L,Cordera R,Brunelli C

    更新日期:2001-04-01 00:00:00

  • Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM)

    abstract:OBJECTIVE:To determine, after 1 yr of follow-up in type II diabetes patients, whether a statistically and clinically significant difference can be achieved in HbA1c between a standard therapy group and an intensively treated group, while maintaining HbA1c levels in both groups within ranges acceptable in regular commun...

    journal_title:Diabetes care

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.2337/diacare.15.11.1560

    authors: Abraira C,Emanuele N,Colwell J,Henderson W,Comstock J,Levin S,Nuttall F,Sawin C

    更新日期:1992-11-01 00:00:00

  • Glycemic control and prevention of retinopathy in Japanese NIDDM patients. A 10-year follow-up study.

    abstract:OBJECTIVE:To examine glycemic control for the prevention of retinopathy in early diagnosed Japanese NIDDM patients. RESEARCH DESIGN AND METHODS:There were 137 patients with NIDDM but without retinopathy who first visited our facility from 1983-1985. Their age at diagnosis ranged from 30-65 years, with a disease durati...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.20.4.621

    authors: Nakagami T,Kawahara R,Hori S,Omori Y

    更新日期:1997-04-01 00:00:00